CALANDO PHARMACEUTICALS, INC.
9Patents
9Active
9Granted
46Portfolio score
Filing activity: Dec 28, 2005 → Aug 10, 2012 · 6 expiring within 5 years
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7427605B2 | Inhibitors of ribonucleotide reductase subunit 2 and uses thereof | Chemistry; Metallurgy | 149 | Active |
| US7807198B2 | Compositions containing inclusion complexes | Chemistry; Metallurgy | 21 | Active |
| US8114983B2 | Compositions and use of EPAS1 inhibitors | Chemistry; Metallurgy | 4 | Active |
| US7968123B2 | Complexing agents for compositions containing inclusion complexes | Chemistry; Metallurgy | 3 | Active |
| US8404662B2 | Cyclodextrin-based polymers for therapeutics delivery | Emerging Cross-Sectional Technologies | 2 | Active |
| US8389499B2 | Cyclodextrin-based polymers for therapeutics delivery | Emerging Cross-Sectional Technologies | 1 | Active |
| US8399431B2 | Cyclodextrin-based polymers for therapeutics delivery | Emerging Cross-Sectional Technologies | 1 | Active |
| US8092833B2 | Compositions containing inclusion complexes | Chemistry; Metallurgy | 1 | Active |
| US8277846B2 | Complexing agents for compositions containing inclusion complexes | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.